Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2016 1
2019 24
2020 5857
2021 11520
2022 12137
2023 9534
2024 2736

Text availability

Article attribute

Article type

Publication date

Search Results

37,382 results

Results by year

Filters applied: . Clear all
Page 1
Recent developments in the immunopathology of COVID-19.
Zhang HP, Sun YL, Wang YF, Yazici D, Azkur D, Ogulur I, Azkur AK, Yang ZW, Chen XX, Zhang AZ, Hu JQ, Liu GH, Akdis M, Akdis CA, Gao YD. Zhang HP, et al. Allergy. 2023 Feb;78(2):369-388. doi: 10.1111/all.15593. Epub 2022 Dec 5. Allergy. 2023. PMID: 36420736 Free PMC article. Review.
The occurrence of new variants of concerns such as Omicron BA.2, BA.4, and BA.5 and the global administration of COVID-19 vaccines have changed the clinical scenario of COVID-19. ...The global distribution of COVID-19 vac …
The occurrence of new variants of concerns such as Omicron BA.2, BA.4, and BA.5 and the global administration of COVID-19 v …
The dawn of mRNA vaccines: The COVID-19 case.
Verbeke R, Lentacker I, De Smedt SC, Dewitte H. Verbeke R, et al. J Control Release. 2021 May 10;333:511-520. doi: 10.1016/j.jconrel.2021.03.043. Epub 2021 Mar 30. J Control Release. 2021. PMID: 33798667 Free PMC article. Review.
The COVID-19 mRNA vaccines represent a new class of vaccine products, which consist of synthetic mRNA strands encoding the SARS-CoV-2 Spike glycoprotein, packaged in lipid nanoparticles to deliver mRNA to cells. This review digs deeper into the …
The COVID-19 mRNA vaccines represent a new class of vaccine products, which consist of synthetic mRNA strands encoding the …
Laboratory testing for the diagnosis of COVID-19.
Lai CKC, Lam W. Lai CKC, et al. Biochem Biophys Res Commun. 2021 Jan 29;538:226-230. doi: 10.1016/j.bbrc.2020.10.069. Epub 2020 Oct 28. Biochem Biophys Res Commun. 2021. PMID: 33139015 Free PMC article. Review.
Rapid and accurate laboratory diagnosis of active COVID-19 infection is one of the cornerstones of pandemic control. ...We will analyze the performance characteristics of laboratory testing techniques of nucleic acid amplification tests, antigen detection tests, ant …
Rapid and accurate laboratory diagnosis of active COVID-19 infection is one of the cornerstones of pandemic control. ...We wil …
COVID-19 in patients with hematologic malignancy.
Langerbeins P, Hallek M. Langerbeins P, et al. Blood. 2022 Jul 21;140(3):236-252. doi: 10.1182/blood.2021012251. Blood. 2022. PMID: 35544585 Free PMC article.
The coronavirus infectious disease (COVID-19) shows a remarkable symptomatic heterogeneity. ...In patients with hematologic malignancy, the immune response to severe acute respiratory syndrome coronavirus 2 (SARS …
The coronavirus infectious disease (COVID-19) shows a remarkable symptomatic heterogeneity. ...In patients with hematol …
Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression.
Feikin DR, Higdon MM, Abu-Raddad LJ, Andrews N, Araos R, Goldberg Y, Groome MJ, Huppert A, O'Brien KL, Smith PG, Wilder-Smith A, Zeger S, Deloria Knoll M, Patel MK. Feikin DR, et al. Lancet. 2022 Mar 5;399(10328):924-944. doi: 10.1016/S0140-6736(22)00152-0. Epub 2022 Feb 23. Lancet. 2022. PMID: 35202601 Free PMC article.
We aimed to systematically review the evidence for the duration of protection of COVID-19 vaccines against various clinical outcomes, and to assess changes in the rates of breakthrough infection caused by the delta variant with increasing time since va …
We aimed to systematically review the evidence for the duration of protection of COVID-19 vaccines against various c …
How to interpret and use COVID-19 serology and immunology tests.
Ong DSY, Fragkou PC, Schweitzer VA, Chemaly RF, Moschopoulos CD, Skevaki C; European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Respiratory Viruses (ESGREV). Ong DSY, et al. Clin Microbiol Infect. 2021 Jul;27(7):981-986. doi: 10.1016/j.cmi.2021.05.001. Epub 2021 May 8. Clin Microbiol Infect. 2021. PMID: 33975005 Free PMC article. Review.
T-cell responses against SARS-CoV-2 have also been detected in recovered COVID-19 patients with no detectable antibodies. ...Combining molecular diagnostics with serological tests may optimize the detection of COVID-19. As not all …
T-cell responses against SARS-CoV-2 have also been detected in recovered COVID-19 patients with no detect …
Temporal Trend of COVID-19 Clinical Severity and the Ethnic/Racial Disparity: A Report from the Maryland Study Group.
Cojocaru L, Pahlavan A, Tadbiri H, Seung H, Reddy R, Mangione ME, Uribe K, Ufua M, Stockett AM, Jones-Beatty K, Burd I, Turan OM, Turan S. Cojocaru L, et al. Am J Perinatol. 2023 Jan;40(2):115-121. doi: 10.1055/s-0042-1757391. Epub 2022 Sep 15. Am J Perinatol. 2023. PMID: 36108638 Review.
We reviewed consecutive charts of adult pregnant females, aged 18 to 55 years, with laboratory-confirmed severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection between March 1, 2020, and February 28, 2 …
We reviewed consecutive charts of adult pregnant females, aged 18 to 55 years, with laboratory-confirmed severe acute respi …
Efficacy and safety of COVID-19 vaccines in older people.
Soiza RL, Scicluna C, Thomson EC. Soiza RL, et al. Age Ageing. 2021 Feb 26;50(2):279-283. doi: 10.1093/ageing/afaa274. Age Ageing. 2021. PMID: 33320183 Free PMC article. Review.
Several vaccines against coronavirus disease 2019 (COVID-19) are on the cusp of regulatory approval. Their safety and efficacy in older people is critical to their success. Even though care home residents and older people are likely to be amongst the f …
Several vaccines against coronavirus disease 2019 (COVID-19) are on the cusp of regulatory approval. Their safety and e …
A comprehensive review of SARS-CoV-2 vaccines: Pfizer, Moderna & Johnson & Johnson.
Patel R, Kaki M, Potluri VS, Kahar P, Khanna D. Patel R, et al. Hum Vaccin Immunother. 2022 Dec 31;18(1):2002083. doi: 10.1080/21645515.2021.2002083. Epub 2022 Feb 7. Hum Vaccin Immunother. 2022. PMID: 35130825 Free PMC article. Review.
Clinical trial results showed the Pfizer and Moderna vaccines to be 95.0%, and the Johnson & Johnson vaccine to be 66.0% effective in protecting against moderate and symptomatic SARS-CoV-2 infection. It is important to keep medical literature updat …
Clinical trial results showed the Pfizer and Moderna vaccines to be 95.0%, and the Johnson & Johnson vaccine to be 66.0% effectiv …
COVID-19 and Inborn Errors of Immunity.
Delmonte OM, Castagnoli R, Notarangelo LD. Delmonte OM, et al. Physiology (Bethesda). 2022 Nov 1;37(6):0. doi: 10.1152/physiol.00016.2022. Epub 2022 Aug 9. Physiology (Bethesda). 2022. PMID: 35944006 Free PMC article. Review.
Inborn errors of immunity (IEI) are a heterogeneous group of disorders affecting immune host defense and immunoregulation. Considering the predisposition to develop severe and chronic infections, it is crucial to understand the clinical evolution of COVID- …
Inborn errors of immunity (IEI) are a heterogeneous group of disorders affecting immune host defense and immunoregulation. Considerin …
37,382 results
You have reached the last available page of results. Please see the User Guide for more information.